Combined pars plana vitrectomy (PPV) and phacoemulsification (phaco) versus PPV and deferred phaco for phakic patients with full-thickness macular hole (FTMH) and no significant cataract at baseline: 1-year outcomes of a randomized trial combined PPV/phaco vs PPV/deferred phaco for MH
Autor: | Karlos Italo Viana, Camila T Gordilho, Andre Messias, Denny Marcos Garcia, Ingrid U. Scott, Marcelo Menegatti Esperandio, Rodrigo Jorge, Felipe Almeida, David R Lucena |
---|---|
Rok vydání: | 2019 |
Předmět: |
Pars plana
medicine.medical_specialty Visual acuity genetic structures medicine.medical_treatment Visual Acuity Vitrectomy Cataract law.invention 03 medical and health sciences Cellular and Molecular Neuroscience 0302 clinical medicine Randomized controlled trial law Ophthalmology Full-thickness macular hole Medicine Humans Macular hole Retrospective Studies Phacoemulsification business.industry medicine.disease Retinal Perforations Sensory Systems medicine.anatomical_structure 030221 ophthalmology & optometry medicine.symptom business Microperimetry 030217 neurology & neurosurgery |
Zdroj: | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 259(1) |
ISSN: | 1435-702X |
Popis: | To compare functional and anatomic outcomes of combined pars plana vitrectomy (PPV) and phacoemulsification (phaco) versus PPV and deferred phaco in patients with full-thickness macular hole (FTMH) and no significant cataract. Thirty-four patients were randomized to group 1 (combined PPV/phaco) and 34 to group 2 (PPV/deferred phaco). Group 2 patients could undergo phaco any time after FTMH surgery if significant cataract developed. Sixty-five patients (33 group 1 and 32 group 2) completed the 12-month visit. Mean ± SEM logMAR best-corrected visual acuity (BCVA) was 0.92 ± 0.04 and 0.90 ± 0.04 at baseline and improved significantly to 0.60 ± 0.05 and 0.58 ± 0.05 at month 12 (p |
Databáze: | OpenAIRE |
Externí odkaz: |